Description
Sermorelin research peptide
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth hormone-releasing hormone, the shortest fully active fragment. It is a classic reference compound for GHRH receptor research.
Product details
| Compound | Sermorelin |
|---|---|
| Class | GHRH analogue (GHRH 1-29) |
| Form | Peptide; Nasal Spray; Sublingual Tablets |
| Strength | 2mg; 10mg; 100mcg per spray/10mg; 200mcg per tablet/10ct/2mg; 200mcg per tablet/20ct/4mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What Sermorelin research has examined
- GHRH receptor signalling: stimulation of pituitary growth hormone release.
- Diagnostic history: formerly used to assess pituitary GH reserve.
- Analogue comparison: benchmark for later GHRH analogues such as CJC-1295 and tesamorelin.
Research interest does not establish a proven effect in humans.
Regulatory status
A sermorelin medicine was previously approved in the US and later discontinued. The material sold here is a research chemical, not a licensed medicine, and is not approved for any use in humans. Growth hormone-releasing factors are prohibited in sport by WADA.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Adamax / Adalank Combo Pack · Healing Research Bundle · Turn Back Time Bundle · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.